Enzymes are super important when it comes to how drugs work. They affect how well medicines work and how safe they are. Enzymes can be sorted into different groups based on what they do, especially in how drugs are broken down, how they interact with each other, and how they are absorbed by the body.
1. Drug Metabolism
- Phase I Reactions: In this stage, enzymes change the drug by adding new parts to it. One type of enzyme called Cytochrome P450 (CYP450) does a lot of this work. About 75% of all drugs are processed by these enzymes. For example, CYP3A4 helps break down more than half of all medicines we use today.
- Phase II Reactions: This stage helps make the drug easier to get rid of by connecting it with other groups that are better at dissolving in water. Enzymes like UDP-glucuronosyltransferases (UGTs) help with this process. Around 15% of drugs go through this glucuronidation step.
2. Drug Targets
- Enzymes can also be the main target for some medicines. For example, statins work by blocking an enzyme called HMG-CoA reductase, which helps make cholesterol. Studies show that statins can lower LDL (bad) cholesterol by up to 60%, which can help prevent heart problems.
- In cancer treatment, some drugs called proteasome inhibitors (like bortezomib) focus on a process called the proteasome pathway, leading to the death of cancer cells. About 40% of patients who take bortezomib see real improvements.
3. Drug Interactions
- Enzymes can also change how drugs work together, which can lead to side effects or make them work less effectively. For instance, if someone takes rifampin (which speeds up enzyme activity) along with antiretroviral drugs, it can lower the amount of those drugs in the bloodstream by up to 90%.
- On the other hand, some foods can slow down enzymes, leading to too much of a drug in the body. For example, grapefruit juice can slow down CYP3A4, increasing the blood levels of some medicines and possibly causing serious side effects.
4. Pharmacogenomics
- Everyone's body is a bit different, and these differences can change how we process drugs. For example, differences in a gene called CYP2D6 can put people into categories of extensive, intermediate, or poor metabolizers. This affects how much medicine they need and how effective it is. About 7-10% of white people are poor metabolizers for drugs broken down by CYP2D6, which can lead to side effects or medicines not working as they should.
In conclusion, enzymes are key players in how drugs work—affecting everything from how we break them down to how our genetics influence their effects. Knowing more about enzymes helps improve medical care and makes treatments more personalized for each person.